<p>We're seeing a steady start to the new day, with the PMI slump from yesterday not really impacting the risk mood all too much. In fact, outside of a sell down in the euro and pound, ther
<p>Organon & Co. OGN and partner Samsung Bioepis Co. Ltd. said Wednesday they have launched their Humira biosimilar Hadlima in the U.S. The move comes after Humira, AbbVie’ Inc.’s ABBV r
Leave a Comment